Literature DB >> 31928434

Cardio-Immuno-Oncology.

Vlad G Zaha1, Wouter C Meijers2, Javid Moslehi2.   

Abstract

Entities:  

Keywords:  cardio-oncology; cardiovascular diseases; immunology; inflammation; medical oncology; myocarditis

Mesh：

Substances：

Year:  2020        PMID： 31928434      PMCID： PMC7192229          DOI： 10.1161/CIRCULATIONAHA.119.042276

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Cardiovascular Toxic Effects of Targeted Cancer Therapies.

Authors:  Javid J Moslehi
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

2.  Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.

Authors:  Joe-Elie Salem; Ali Manouchehri; Melissa Moey; Bénédicte Lebrun-Vignes; Lisa Bastarache; Antoine Pariente; Aurélien Gobert; Jean-Philippe Spano; Justin M Balko; Marc P Bonaca; Dan M Roden; Douglas B Johnson; Javid J Moslehi
Journal:  Lancet Oncol       Date:  2018-11-12       Impact factor: 41.316

3.  Immunotherapy for cardiovascular disease.

Authors:  Esther Lutgens; Dorothee Atzler; Yvonne Döring; Johan Duchene; Sabine Steffens; Christian Weber
Journal:  Eur Heart J       Date:  2019-12-21       Impact factor: 29.983

Review 4.  Comprehensive analysis of the clinical immuno-oncology landscape.

Authors:  J Tang; A Shalabi; V M Hubbard-Lucey
Journal:  Ann Oncol       Date:  2018-01-01       Impact factor: 32.976

5.  Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology.

Authors:  Peter Libby; Sebastian Kobold
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787
  5 in total
  11 in total

Review 1.  Training and Career Development in Cardio-Oncology Translational and Implementation Science.

Authors:  Sherry-Ann Brown; Eric H Yang; Mary Branch; Craig Beavers; Anne Blaes; Michael G Fradley; Richard K Cheng
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

2.  Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.

Authors:  Yuki Nakagomi; Kazuko Tajiri; Saori Shimada; Siqi Li; Keiko Inoue; Yoshiko Murakata; Momoko Murata; Shunsuke Sakai; Kimi Sato; Masaki Ieda
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

Review 3.  Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer.

Authors:  Pilar Martín; Rafael Blanco-Domínguez; Raquel Sánchez-Díaz
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

4.  Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets.

Authors:  Wei Feng Ma; Chani J Hodonsky; Adam W Turner; Doris Wong; Yipei Song; Jose Verdezoto Mosquera; Alexandra V Ligay; Lotte Slenders; Christina Gancayco; Huize Pan; Nelson B Barrientos; David Mai; Gabriel F Alencar; Katherine Owsiany; Gary K Owens; Muredach P Reilly; Mingyao Li; Gerard Pasterkamp; Michal Mokry; Sander W van der Laan; Bohdan B Khomtchouk; Clint L Miller
Journal:  Atherosclerosis       Date:  2021-11-26       Impact factor: 5.162

Review 5.  Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies.

Authors:  Ashley F Stein-Merlob; Michael V Rothberg; Patrick Holman; Eric H Yang
Journal:  Curr Cardiol Rep       Date:  2021-01-22       Impact factor: 2.931

Review 6.  Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research.

Authors:  Jean C Bikomeye; Andreas M Beyer; Jamila L Kwarteng; Kirsten M M Beyer
Journal:  Int J Environ Res Public Health       Date:  2022-02-19       Impact factor: 3.390

Review 7.  The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and Beyond.

Authors:  Dan Gilon; Zaza Iakobishvili; David Leibowitz
Journal:  Vaccines (Basel)       Date:  2022-02-16

Review 8.  ICIs-Related Cardiotoxicity in Different Types of Cancer.

Authors:  Mei Dong; Ting Yu; Zhenzhen Zhang; Jing Zhang; Rujian Wang; Gary Tse; Tong Liu; Lin Zhong
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-28

9.  Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.

Authors:  Xinyu Yang; Guoping Li; Manke Guan; Aneesh Bapat; Qianqian Dai; Changming Zhong; Tao Yang; Changyong Luo; Na An; Wenjing Liu; Fan Yang; Haie Pan; Pengqian Wang; Yonghong Gao; Ye Gong; Saumya Das; Hongcai Shang; Yanwei Xing
Journal:  Front Cardiovasc Med       Date:  2021-06-04

Review 10.  Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy.

Authors:  Kazuko Tajiri; Saori Yonebayashi; Siqi Li; Masaki Ieda
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.